Hearing Aid Noise Reduction in Pediatric Users Pilot Study (Oticon Pilot Study)

checkorphan
Learn more about:
Sensorineural hearing loss
Related Clinical Trial
The Performance of a Robot-assisted Minimally Invasive Direct Cochlear Access for Cochlear Implantation Auditory Performances With Different Stimulation Depths in Cochlear Implanted Subjects Using a Fine Structure Strategy Feasibility of the Mi2000 Totally Implantable Cochlear Implant in Severely to Profoundly Deaf Adults. Hearing Aid Noise Reduction in Pediatric Users Pilot Study (Oticon Pilot Study) Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss Dexamethasone-Eluting Cochlear Implant Electrode Artificial Intelligence in Diagnosis of DFNA9 Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC Cochlear Implant and Vestibular Function. Quality Control of CE-Certified Phonak Hearing Aids – 2018_42 Quality Control of CE-Certified Phonak Hearing Aids – 2018_28 Enlarged Vestibular Aqueduct Registry Evaluation of the High Frequency Digit Triplet Test in Cystic Fibrosis Effectiveness of P02 Digital Hearing Aids ABR Characteristics and Salivary Cortisone Concentration in Noise-exposed Workers Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population Genetic Analysis of Hereditary Disorders of Hearing and Balance Compassionate Use Arm – ABI541 ABI for 10 NF2 Patients Evaluation of a Binaural Beamformer (StereoZoom) in a Virtual Acoustic Environment and in Real Life Evaluation of N6 Sound Processor in Group of Freedom Users Robotic Assisted Cochlear Implantation Feasibility Study Auditory Nerve Test System During Vestibular Schwannoma Resection Cochlear Electrical Impedance and the Effect of Topical Dexamethasone on Cochlear Implant Surgery Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors Listening Effort in Cochlear Implant Users Quality Control of CE-Certified Phonak Hearing Aids – 2019_19 Esteem Totally Implantable Hearing System A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease Study of Quality Perception on Music in New Cochlear Implanted Subjects Using or Not a Fine Structure Strategy An Evidence Based Delivery Model of Care for Newly Implanted Adult CI Recipients Study of Auditory Performance on Prosodic Tests in Cochlear Implanted Subjects Using a Fine Structure Strategy CI532 – Early Experience Study Clinical Applications of Round Window Imaging Anatomy in Cochlear Implant Surgery Single-sided Deafness and Cochlear Implants Cochlear Implantation Among Adults and Older Children With Unilateral or Asymmetric Hearing Loss Clinal Evaluation of Navigation Based Functional Ear Surgery Using Image Guided and Robotically Assisted Techniques OTO-413 in Subjects With Speech-in-Noise Hearing Impairment The Efficacy of a Minimally Invasive Direct Cochlear Access Via the HEARO Procedure Clinical Evaluation of a Cochlear Implant System Objective Measures in Cochlear Implant Evaluation of a Binaural Spatialization Method for Hearing Aids Esteem New Subject Enrollment Post Approval Study Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss Investigation of Anatomical Correlates of Speech Discrimination Efficacy of Digital Noise Reduction Strategies: A Hearing Aid Trial Evaluation of Revised Indicatons (ERID) for Cochlear Implant Candidacy for the Adult CMS Population Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts Balance in Children With Cochlear Implants Congenital Cytomegalovirus: Efficacy of Antiviral Treatment Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System Radiological Classification of the Facial Nerve Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial The Effect of Sound Stimulation on Hearing Ability The Effect of Sound Stimulation on Pure-tone Hearing Threshold Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss The SeaSHeL National Prospective Cohort Study Non-linear Frequency Compared to Conventional Processing in Patients With and Without Cochlear Dead Regions. Study of Low Level Laser Therapy and Word Recognition in Hearing Impaired Individuals Electrode Placement and Audiologic Outcomes With the Advanced Bionics HiFocus L23 Electrode Video HIT in Sudden Sensorineural Hearing Loss Determine the Incidence of Long QT Amongst a Large Cohort of Subjects Diagnosed With Unilateral or Bilateral Sensorineural Hearing Loss. FX-322 in Sensorineural Hearing Loss Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss FX-322 in Adults With Stable Sensorineural Hearing Loss

Brief Title

Hearing Aid Noise Reduction in Pediatric Users Pilot Study (Oticon Pilot Study)

Official Title

Short-Term Pediatric Acclimatization to Adaptive Hearing Aid Technology

Brief Summary

      The purpose of this study is to evaluate the efficacy of OpenSound Navigator (OSN), a hearing
      aid speech-enhancement algorithm developed by Oticon, as treatment for pediatric hearing aid
      users. The study used a within-subjects design with pre- and post-comparisons involving
      fifteen pediatric (ages 6-12) patients with symmetrical sensorineural hearing losses ranging
      from the mild to moderately-severe degree. All participants were fit with bilateral Oticon
      OPN™ behind-the-ear hearing aids set with the OSN algorithm enabled. The investigators
      evaluated hearing aid benefit through word recognition in noise (behavioral testing) and
      everyday hearing/listening abilities (parental/legal guardian reported) within one week of
      the hearing aid fitting (pre-intervention) and two months post fitting (post-intervention).

Detailed Description

      OpenSound Navigator (OSN) is a speech enhancement hearing aid algorithm developed by Oticon
      that utilizes an adaptive directional microphone system with an automatic gain control noise
      reduction program. This hearing aid feature is intended for adult hearing aid users and its
      potential benefits of speech, vocabulary and listening development in pediatric users has not
      been investigated. Here the investigators aim to evaluate the efficacy of OSN programming in
      pediatric hearing aid users (6-12 years of age) diagnosed with a symmetrical sensorineural
      hearing loss in the mild to moderately-severe range. The investigators used a within-subjects
      study design with pre- and post-comparisons. All participants were fit with bilateral Oticon
      OPN™ behind-the-ear hearing aids with the OSN feature enabled. Participants will undergo
      standard audiometric diagnostic testing and will be fit with the hearing aids by a licensed
      clinical audiologist. Participants are required to wear the hearing aids full time (at least
      6 hours per day average) during the duration of the study. The evaluation measures will
      include speech recognition testing in controlled background noise and the Speech, Spatial and
      Qualities of Hearing Scale questionnaire (completed by parents/legal guardian). Testing will
      be performed within a week of the hearing aid fitting (pre-intervention) and two months post
      fitting (post-intervention).

Study Type

Interventional

Primary Outcome

Word Recognition in Noise Abilities

Secondary Outcome

 Speech, Spatial Qualities of Hearing Scale (SSQ) Scores

Condition

Hearing Impairment

Intervention

Oticon OpenSound Navigator speech enhancement algorithm

Study Arms / Comparison Groups

 Exploratory
Description:  Participants were fit with Oticon OPN™ behind-the-ear hearing aids with the OpenSound Navigator algorithm enabled. Pre-intervention measures were obtained within one week of the hearing aid fit and post-intervention measures were obtained after two months of daily hearing aid use.

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status

Device

Estimated Enrollment

15

Start Date

March 5, 2018

Completion Date

September 30, 2018

Primary Completion Date

September 30, 2018

Eligibility Criteria

        Inclusion Criteria:

          -  children ages 6 to 12 years

          -  English as the primary home language

          -  positive for bilateral symmetrical mild to moderately-severe sensorineural hearing
             loss

          -  currently using hearing aids that were dispensed at least 18 months prior to
             enrollment of the study

          -  negative for major cognitive handicap or developmental delay that would prevent or
             restrict participation, as determined by the PI or designee

          -  negative for learning disability, for example attention-deficit/hyperactivity
             disorder, as determined by the PI or designee

          -  negative for serious neurological or psychiatric disease that would prevent or
             restrict participation, as determined by the PI or designee

          -  informed consent of parent/guardian

          -  assent of participating child if aged 11 years and over

          -  standard MRI inclusion criteria as set by the Cincinnati Children's Hospital Medical
             Center department of Radiology

          -  not currently pregnant or breast feeding

          -  willingness and ability of the participant and/or the participant's caregiver to
             comply with study requirements

          -  no history of medical neglect of caregiver

Gender

All

Ages

6 Years - 12 Years

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

David R Moore, Ph.D., ,

Location Countries

United States

Location Countries

United States

Administrative Informations

NCT ID

NCT04469946

Organization ID

2017-5953-2

Responsible Party

Sponsor

Study Sponsor

Children's Hospital Medical Center, Cincinnati

Study Sponsor

David R Moore, Ph.D., Principal Investigator, Children's Hospital Medical Center, Cincinnati

Verification Date

June 2020